S-3 GROUP

Lobbying for GOODRX · Healthcare company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $20,000.00 income · posted Jul 18, 2025

Lobbying activity 2

Pharmacy

Issues regarding lower prescription drug prices for patients

Health Issues

Issues regarding lower prescription drug prices for patients

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.